Home›Companies›Biotech & Pharma›Arrivo BioVentures

Arrivo BioVentures, LLC

Updated Oct 29, 2026·Latest SEC filing Nov 29, 2023·Suggest an edit

About Arrivo BioVentures

Arrivo BioVentures is a private company based in Morrisville, North Carolina. It has reported $92,194,016 raised in two offerings on Form D since May 2016.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 17, 2023Nov 29, 2023$43,194,016of $45.2M target58$744KEquityRule 506(b)Form D ↗
May 10, 2016May 25, 2016$49,000,000fully sold34$1.4MEquity, Fund interestsRule 506(b)Form D ↗
Total, two offerings$92,194,016

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Arrivo BioVentures's Form D filed Nov 29, 2023.

KA
Karen Adams
Executive officer
SB
Stephen Butts
President

Earlier filings also listed William Wofford (secretary, last listed May 2016).

Sources

  1. SECArrivo BioVentures, LLC filing history